Coronavirus disease 2019 and cardiovascular disease: what we have learnt during the last 2 years.

[1]  C. Specchia,et al.  Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study , 2022, Journal of cardiovascular medicine.

[2]  Yuehua Wu,et al.  Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases , 2022, The Lancet.

[3]  Z. Al-Aly,et al.  Long COVID after breakthrough SARS-CoV-2 infection , 2022, Nature Medicine.

[4]  C. Giannattasio,et al.  Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis , 2022, Circulation.

[5]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[6]  S. Pelenghi,et al.  Coronavirus disease 2019 and cardiac surgery: lessons learnt from a round-trip to hell. , 2022, Journal of cardiovascular medicine.

[7]  Manfred S. Green,et al.  Myocarditis after BNT162b2 Vaccination in Israeli Adolescents , 2022, The New England journal of medicine.

[8]  Michael John Smith,et al.  Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. , 2022, JAMA.

[9]  C. Specchia,et al.  Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study , 2022, Journal of cardiovascular medicine.

[10]  G. Campo,et al.  Left atrial pressure in patients with respiratory failure due to SARS-CoV-2 infection and supraventricular arrythmias , 2022, Journal of cardiovascular medicine.

[11]  M. di Mauro,et al.  The day after tomorrow: cardiac surgery and coronavirus disease-2019 , 2021, Journal of cardiovascular medicine.

[12]  M. Zuin,et al.  Echocardiographic systolic pulmonary arterial pressure and mortality in coronavirus disease 2019 patients , 2020, Journal of cardiovascular medicine.

[13]  G. Hindricks,et al.  ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up , 2021, European heart journal.

[14]  F. Asch,et al.  Ventricular Changes in Patients with Acute COVID-19 Infection: Follow-up of the World Alliance Societies of Echocardiography (WASE-COVID) Study , 2021, Journal of the American Society of Echocardiography.

[15]  G. Mascioli,et al.  Reduction of admissions for urgent and elective pacemaker implant during the COVID-19 outbreak in Northern Italy , 2021, Journal of cardiovascular medicine.

[16]  M. Metra,et al.  High troponin levels in patients hospitalized for coronavirus disease 2019: a maker or a marker of prognosis? , 2021, Journal of cardiovascular medicine.

[17]  M. Volpe,et al.  Coronavirus disease 2019 in patients with cardiovascular disease: clinical features and implications on cardiac biomarkers assessment , 2021, Journal of cardiovascular medicine.

[18]  M. Metra,et al.  COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae , 2021, Frontiers in Cardiovascular Medicine.

[19]  J. Mehta,et al.  Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines , 2021, Journal of cardiovascular medicine.

[20]  E. Seminari,et al.  QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine , 2021, Journal of Cardiovascular Medicine.

[21]  P. Farrington,et al.  Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study , 2021, The Lancet.

[22]  C. Specchia,et al.  Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[23]  A. Chiti,et al.  In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients , 2021, Journal of cardiovascular medicine.

[24]  P. Pagliaro,et al.  Angiotensin-converting enzyme 2: a key enzyme in key organs , 2021, Journal of cardiovascular medicine.

[25]  E. Picano,et al.  Remodeling of activities of Italian echocardiographic laboratories during the coronavirus disease 2019 lockdown: the SIECoVId study , 2021, Journal of cardiovascular medicine.

[26]  A. Curcio,et al.  Therapy with RAS inhibitors during the COVID-19 pandemic. , 2021, Journal of cardiovascular medicine.

[27]  M. Imazio,et al.  Pericarditis in patients with COVID-19: a systematic review , 2021, Journal of cardiovascular medicine.

[28]  M. Metra,et al.  Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation , 2021, Current Heart Failure Reports.

[29]  F. Crea,et al.  Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience , 2021, Journal of cardiovascular medicine.

[30]  J. Loscalzo,et al.  COVID-19 and Cardiovascular Disease , 2021, Circulation research.

[31]  G. Di Salvo,et al.  Impact of hard lockdown on interventional cardiology procedures in congenital heart disease: a survey on behalf of the Italian Society of Congenital Heart Disease , 2021, Journal of cardiovascular medicine.

[32]  A. Curnis,et al.  Could Home Monitoring parameters provide information about the impact of the pandemic period on CIED patients? A comparison between 2019 and 2020 , 2021, Journal of cardiovascular medicine.

[33]  F. Romeo,et al.  Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort. , 2021, Journal of cardiovascular medicine.

[34]  P. Kellman,et al.  Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance , 2021, European heart journal.

[35]  M. Mapelli,et al.  Feasibility of remote home monitoring with a T-shirt wearable device in post-recovery COVID-19 patients , 2021, Journal of Cardiovascular Medicine.

[36]  M. Metra,et al.  Renin–angiotensin–aldosterone inhibitors and COVID‐19: nearing the end of a media‐fuelled controversy , 2021, European journal of heart failure.

[37]  E. Fabris,et al.  COVID-19 impact on ST-elevation myocardial infarction incidence rate in a Italian STEMI network: a U-shaped curve phenomenon , 2021, Journal of cardiovascular medicine.

[38]  A. Rapacciuolo,et al.  Cardiac pacing procedures during coronavirus disease 2019 lockdown in Southern Italy: insights from Campania Region , 2021, Journal of cardiovascular medicine.

[39]  OUP accepted manuscript , 2021, European Heart Journal.

[40]  A. Şen,et al.  Evaluation of P-wave dispersion in patients with newly diagnosed coronavirus disease 2019. , 2020, Journal of cardiovascular medicine.

[41]  S. Iliceto,et al.  Characteristics and hospital course of patients admitted for acute cardiovascular diseases during the coronavirus disease-19 outbreak , 2020, Journal of cardiovascular medicine.

[42]  G. Parodi,et al.  Type 2 myocardial infarction in patients with coronavirus disease 2019 , 2020, Journal of cardiovascular medicine.

[43]  M. Metra,et al.  Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study , 2020, European journal of heart failure.

[44]  M. Metra,et al.  Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study , 2020, Clinical Research in Cardiology.

[45]  A. Santarelli,et al.  Impact of the COVID-19 pandemic on coronary invasive procedures at two Italian high-volume referral centers , 2020, Journal of cardiovascular medicine.

[46]  F. Guerra,et al.  Reduction in acute coronary syndromes during coronavirus disease 2019 global pandemic: data from the Marche region of Italy. , 2020, Journal of cardiovascular medicine.

[47]  M. Metra,et al.  Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction , 2020, Journal of cardiovascular medicine.

[48]  A. Mebazaa,et al.  Unusual arterial thrombotic events in Covid-19 patients , 2020, International Journal of Cardiology.

[49]  J. Mehta,et al.  Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications. , 2020, Journal of cardiovascular medicine.

[50]  M. Metra,et al.  Coronavirus disease 2019 and cardiovascular implications. , 2020, Journal of cardiovascular medicine.

[51]  R. Andrea,et al.  Thrombosis and bleeding in critical Coronavirus disease-2019 patients: two sides of the same coin. , 2020, Journal of cardiovascular medicine.

[52]  Marco Merlo,et al.  Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. , 2020, JAMA cardiology.

[53]  C. Pedrinazzi,et al.  Transient ST-segment elevation in coronavirus disease-2019. , 2020, Journal of Cardiovascular Medicine.

[54]  G. Luciani,et al.  Resilience and response of the congenital cardiac network in Italy during the COVID-19 pandemic. , 2020, Journal of cardiovascular medicine.

[55]  Eike Nagel,et al.  Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[56]  David B. Lewis,et al.  COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives , 2020, Nature Reviews Cardiology.

[57]  M. Zuin,et al.  Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis. , 2020, Journal of cardiovascular medicine.

[58]  A. Colli,et al.  Lombardy regional urgent reorganization for congenital cardiac patients following the Covid-19 pandemic. , 2020, Journal of cardiovascular medicine.

[59]  S. Buccheri,et al.  Impact on hospital admission of ST-elevation myocardial infarction patients during coronavirus disease 2019 pandemic in an Italian Hospital , 2020, Journal of cardiovascular medicine.

[60]  Angelo Carfì,et al.  Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.

[61]  I. Porto,et al.  Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: lessons from the coronavirus disease 2019 lockdown in Italy , 2020, Journal of cardiovascular medicine.

[62]  M. Imazio,et al.  COVID-19 and myocardial injury: is there a role for interleukin-1 inhibition? , 2020, Journal of cardiovascular medicine.

[63]  G. Di Salvo,et al.  Cardiac imaging in congenital heart disease during the coronavirus disease-2019 pandemic: recommendations from the Working Group on Congenital Heart Disease of the Italian Society of Cardiology , 2020, Journal of cardiovascular medicine.

[64]  P. Ponikowski,et al.  Management of heart failure patients with COVID‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology , 2020, European journal of heart failure.

[65]  S. Solomon,et al.  COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease , 2020, European journal of heart failure.

[66]  Hesong Zeng,et al.  Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging , 2020, JACC: Cardiovascular Imaging.

[67]  C. Specchia,et al.  Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy , 2020, European heart journal.

[68]  G. Mancia,et al.  Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 , 2020, The New England journal of medicine.

[69]  Catherine Klersy,et al.  Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy , 2020, The New England journal of medicine.

[70]  J. Mehta,et al.  Coronavirus disease 2019 infection and the cardiovascular system. , 2020, Journal of cardiovascular medicine.